Cargando…
Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers
Cell therapy using renal progenitors differentiated from human embryonic stem cells (hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce the number of patients receiving dialysis therapy. However, the differentiation cultures may contain undifferentiated or un...
Autores principales: | Hoshina, Azusa, Kawamoto, Tatsuya, Sueta, Shin-Ichi, Mae, Shin-Ichi, Araoka, Toshikazu, Tanaka, Hiromi, Sato, Yasunori, Yamagishi, Yukiko, Osafune, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913312/ https://www.ncbi.nlm.nih.gov/pubmed/29686294 http://dx.doi.org/10.1038/s41598-018-24714-3 |
Ejemplares similares
-
Author Correction: Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers
por: Hoshina, Azusa, et al.
Publicado: (2019) -
iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome
por: Hirayama, Ryuichiro, et al.
Publicado: (2023) -
Efficient and Rapid Induction of Human iPSCs/ESCs into Nephrogenic Intermediate Mesoderm Using Small Molecule-Based Differentiation Methods
por: Araoka, Toshikazu, et al.
Publicado: (2014) -
Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells
por: Katagiri, Naoko, et al.
Publicado: (2021) -
iPSC technology-based regenerative medicine for kidney diseases
por: Osafune, Kenji
Publicado: (2021)